Anteris Technologies Glb (AVR) closed at $5.87 on October 23, 2026, down 2.2% from the previous close, on volume of 868,596 shares (30-day average 1,238,154).
Data as of October 23, 2026.
23-Oct-2026
Anteris Advances Global PARADIGM Trial Expansion with German Regulatory Clearance
Globe Newswire (Mon, 19-Oct 9:12 PM ET)
Anteris to Present at September Healthcare Investor Conferences
Globe Newswire (Mon, 31-Aug 2:45 PM ET)
Anteris Technologies Announces Results for the Second Quarter of 2026
Globe Newswire (Tue, 11-Aug 7:00 PM ET)
Anteris Bolsters U.S. Momentum as CMS Reimbursement Unlocks PARADIGM Trial Site Activations
Market Chameleon (Tue, 28-Apr 4:00 AM ET)
Medtronic’s $90 Million Investment Propels Anteris’ TAVR Ambitions—What’s Next for the DurAVR Valve?
Market Chameleon (Fri, 23-Jan 3:31 AM ET)
Market Chameleon (Tue, 28-Oct 3:46 AM ET)
Anteris Technologies Global Corp is a structural heart company focused on advancing cardiac care through science-driven innovations aimed at restoring heart valve patients to healthy function. Its key product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with interventional cardiologists and cardiac surgeons to treat Aortic Stenosis, a potentially life-threatening condition caused by narrowing of the aortic valve. The balloon-expandable DurAVR THV is a biomimetic valve designed to mimic the performance of a healthy human aortic valve and replicate normal aortic blood flow. The company operates in United States, Germany, Australia, Switzerland, and Sweden, with the majority of its revenue generated from the United States.
Anteris Technologies Glb trades on the NASDAQ stock market under the symbol AVR.
As of October 23, 2026, AVR stock price declined to $5.87 with 868,596 million shares trading.
AVR has a beta of 1.89, meaning it tends to be more sensitive to market movements. AVR has a correlation of 0.11 to the broad based SPY ETF.
AVR has a market cap of $572.08 million. This is considered a Small Cap stock.
Last quarter Anteris Technologies Glb reported $1 million in Revenue and -$.30 earnings per share. This fell short of revenue expectation by $-1 million and missed earnings estimates by -$.09.
The top ETF exchange traded funds that AVR belongs to (by Net Assets): IWM, VXF, IWN, VTWO, SCHA.
AVR has underperformed the market in the last year with a price return of +5.0% while the SPY ETF gained +14.3%. AVR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -28.3% and -13.3%, respectively, while the SPY returned +3.2% and -2.4%, respectively.
AVR support price is $5.79 and resistance is $6.21 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AVR shares will trade within this expected range on the day.
